Divergence of Cofactor Recognition across Evolution: Coenzyme A Binding in a Prokaryotic Arylamine N-Acetyltransferase

Journal of Molecular Biology

Volumn 375, Issue 1, 2008, Pages 178-191

  Fullam, Elizabeth ^a   Westwood, Isaac M ^a   Anderton, Matthew C ^a   Lowe, Edward D ^b   Sim, Edith ^a   Noble, Martin E M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acetyl coenzyme A; arylamine N acetyltransferase; Mycobacterium marinum; X ray crystallography

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; COENZYME A; GENOMIC DNA; ISONIAZID; RECOMBINANT PROTEIN; XENOBIOTIC AGENT;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ENZYME BINDING; GENE; GENE AMPLIFICATION; GENOMICS; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NAT GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROKARYOTE; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN INTERACTION; SALMONELLA TYPHIMURIUM; SEQUENCE ALIGNMENT; X RAY CRYSTALLOGRAPHY;

CORYNEBACTERINEAE; MAMMALIA; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA;

EID: 36348945257     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.10.019     Document Type: Article

References (48)

1. Weber W.W., and Hein D.W. N-Acetylation pharmacogenetics. Pharmacol. Rev. 37 (1985) 25-79
2. King C.M., Land S.J., Jones R.F., Debiec-Rychter M., Lee M.S., and Wang C.Y. Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat. Res. 376 (1997) 123-128
3. Hein D.W., Rustan T.D., Ferguson R.J., Doll M.A., and Gray K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol. 68 (1994) 129-133
4. Hein D.W., Rustan T.D., Doll M.A., Bucher K.D., Ferguson R.J., Feng Y., et al. Acetyltransferases and susceptibility to chemicals. Toxicol. Lett. (1992) 64-65 Spec. Issue No. 123-30
5. Lipmann F. On chemistry and function of coenzyme A. Bacteriol. Rev. 17 (1953) 1-16
6. Riddle B., and Jencks W.P. Acetyl-coenzyme A: arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate. J. Biol. Chem. 246 (1971) 3250-3258
7. Watanabe M., Sofuni T., and Nohmi T. Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. J. Biol. Chem. 267 (1992) 8429-8436
8. Jencks W.P., Gresser M., Valenzuela M.S., and Huneeus F.C. Acetyl coenzyme A: arylamine acetyltransferase. Measurement of the steady state concentration of the acetyl-enzyme intermediate. J. Biol. Chem. 247 (1972) 3756-3760
9. Upton A., Smelt V., Mushtaq A., Aplin R., Johnson N., Mardon H., and Sim E. Placental arylamine N-acetyltransferase type 1: potential contributory source of urinary folate catabolite p-acetamidobenzoylglutamate during pregnancy. Biochim. Biophys. Acta 1524 (2000) 143-148
10. Minchin R.F. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem. J. 307 (1995) 1-3
11. Floss H.G., and Yu T.W. Lessons from the rifamycin biosynthetic gene cluster. Curr. Opin. Chem. Biol. 3 (1999) 592-597
12. Sinclair J.C., Sandy J., Delgoda R., Sim E., and Noble M.E. Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat. Struct. Biol. 7 (2000) 560-564
13. Sandy J., Mushtaq A., Holton S.J., Schartau P., Noble M.E., and Sim E. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines. Biochem. J. 390 (2005) 115-123
14. Sandy J., Mushtaq A., Kawamura A., Sinclair J., Sim E., and Noble M. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis-an enzyme which inactivates the anti-tubercular drug, isoniazid. J. Mol. Biol. 318 (2002) 1071-1083
15. Westwood I.M., Kawamura A., Fullam E., Russell A.J., Davies S.G., and Sim E. Structure and mechanism of arylamine N-acetyltransferases. Curr. Top. Med. Chem. 6 (2006) 1641-1654
16. Holton S.J., Dairou J., Sandy J., Rodrigues-Lima F., Dupret J.M., Noble M.E., and Sim E. Structure of Mesorhizobium loti arylamine N-acetyltransferase 1. Acta Crystallogr. Sect. F 61 (2005) 14-16
17. Zhang N., Liu L., Liu F., Wagner C.R., Hanna P.E., and Walters K.J. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity. J. Mol. Biol. 363 (2006) 188-200
18. Wu H., Tempel W., Dombrovski L., Loppnau P., Weigelt J., Sundstrom M., et al. J. Biol. Chem. (2007) online manuscript
19. Sim E., Westwood I., and Fullam E. Arylamine N-acetyltransferases. Expert Opin. Drug Metab. Toxicol. 3 (2007) 169-184
20. Sandy J., Holton S., Fullam E., Sim E., and Noble M. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis. Protein Sci. 14 (2005) 775-782
21. Westwood I.M., and Sim E. Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa. BMC Biochem. 8 (2007) 3
22. Upton A.M., Mushtaq A., Victor T.C., Sampson S.L., Sandy J., Smith D.M., et al. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol. Microbiol. 42 (2001) 309-317
23. Evans D.A.P., Manley K.A., and McKuisick V.A. Genetic control of isoniazid acetylation in man. Br. Med. J. 2 (1960) 485-491
24. Bhakta S., Besra G.S., Upton A.M., Parish T., Gibson K.J.C., Knutton S., et al. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J. Exp. Med. 199 (2004) 1-9
25. Tonjum T., Welty D.B., Jantzen E., and Small P.L. Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis. J. Clin. Microbiol. 36 (1998) 918-925
26. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
27. Camus J.C., Pryor M.J., Medigue C., and Cole S.T. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148 (2002) 2967-2973
28. Sinclair J.C., Delgoda R., Noble M.E., Jarmin S., Goh N.K., and Sim E. Purification, characterization, and crystallization of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium. Protein Expression Purif. 12 (1998) 371-380
29. Brooke E.W., Davies S.G., Mulvaney A.W., Pompeo F., Sim E., and Vickers R.J. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases. Bioorg. Med. Chem. 11 (2003) 1227-1234
30. Wang H., Vath G.M., Gleason K.J., Hanna P.E., and Wagner C.R. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies. Biochemistry 43 (2004) 8234-8246
31. Ramachandran G.N., Ramakrishnan C., and Sasisekharan V. Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 7 (1963) 95-99
32. Sandy J., Mushtaq A., Kawamura A., Sinclair J., Sim E., and Noble M. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis-an enzyme which inactivates the anti-tubercular drug, isoniazid. J. Mol. Biol. 318 (2002) 1071-1083
33. Dyda F., Klein D.C., and Hickman A.B. GCN5-related N-acetyltransferases: a structural overview. Annu. Rev. Biophys. Biomol. Struct. 29 (2000) 81-103
34. Engel C., and Wierenga R. The diverse world of coenzyme A binding proteins. Curr. Opin. Struct. Biol. 6 (1996) 790-797
35. Andres H.H., Kolb H.J., and Weiss L. Purification and physical-chemical properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver. Biochim. Biophys. Acta 746 (1983) 182-192
36. Kawamura, A. (2005). Structural investigations of arylamine N-acetyltransferases from eukaryotes. PhD dissertation, University of Oxford.
37. Zang Y., Doll M.A., Zhao S., States J.C., and Hein D.W. Functional characterization of single nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. Carcinogenesis 28 (2007) 1665-1671
38. Upton A., Johnson N., Sandy J., and Sim E. Arylamine N-acetyltransferases-of mice, men and microorganisms. Trends Pharmacol. Sci. 22 (2001) 140-146
39. Andres H.H., Klem A.J., Szabo S.M., and Weber W.W. New spectrophotometric and radiochemical assays for acetyl-CoA:arylamine N-acetyltransferase applicable to a variety of arylamines. Anal. Biochem. 145 (1985) 367-375
40. Mushtaq A., Payton M., and Sim E. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity. J. Biol. Chem. 277 (2002) 12175-12181
41. Sinclair J., and Sim E. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis. Biochem. Pharmacol. 53 (1997) 11-16
42. Sambrook J., Fritsch E.F., and Maniatis T. In: Press C.S.H.L. (Ed). Molecular Cloning. A Laboratory Manual. 2nd edit. (1989), Cold Spring Harbor, New York
43. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
44. Collaborative Computational Project. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50 (1994) 760-763
45. Read R.J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. Sect. D 57 (2001) 1373-1382
46. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D 60 (2004) 2126-2132
47. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D 53 (1997) 240-255
48. Bergh S., and Cole S.T. Using MycDB on the World-Wide Web. Methods Mol. Biol. 101 (1998) 109-118